Given prior evidence suggesting that KL-VSHET mitigates AD pathology predominantly in APOE ε4 carriers, we hypothesized that associations between KL-VSHET and both cognitive performance and likelihood of classification as AD would be stronger in individuals carrying the APOE ε4 allele. Here, APOE is linked to Alzheimer disease.